Srivastava S - Search Results

1

Sreenath TL, Macalindong SS, Mikhalkevich N, Sharad S, Mohamed A, Young D, Borbiev T, Xavier C, Gupta R, Jamal M, Babcock K, Tan SH, Nevalainen MT, Dobi A, Petrovics G, Sesterhenn IA, Rosner IL, Bieberich CJ, Nelson P, Vasioukhin V, Srivastava S. Sreenath TL, et al. Among authors: srivastava s. Sci Rep. 2017 Apr 24;7(1):1109. doi: 10.1038/s41598-017-01187-4. Sci Rep. 2017. PMID: 28439080 Free PMC article.

2

p53 and bcl-2 immunohistochemistry in pretreatment prostate needle biopsies to predict recurrence of prostate cancer after radical prostatectomy.

Stackhouse GB, Sesterhenn IA, Bauer JJ, Mostofi FK, Connelly RR, Srivastava SK, Moul JW. Stackhouse GB, et al. Among authors: srivastava sk. J Urol. 1999 Dec;162(6):2040-5. doi: 10.1016/S0022-5347(05)68095-0. J Urol. 1999. PMID: 10569564

3

Maspin expression profile in human prostate cancer (CaP) and in vitro induction of Maspin expression by androgen ablation.

Zou Z, Zhang W, Young D, Gleave MG, Rennie P, Connell T, Connelly R, Moul J, Srivastava S, Sesterhenn I. Zou Z, et al. Among authors: srivastava s. Clin Cancer Res. 2002 May;8(5):1172-7. Clin Cancer Res. 2002. PMID: 12006534

4

Limitations of tissue microarrays in the evaluation of focal alterations of bcl-2 and p53 in whole mount derived prostate tissues.

Merseburger AS, Kuczyk MA, Serth J, Bokemeyer C, Young DY, Sun L, Connelly RR, McLeod DG, Mostofi FK, Srivastava SK, Stenzl A, Moul JW, Sesterhenn IA. Merseburger AS, et al. Among authors: srivastava sk. Oncol Rep. 2003 Jan-Feb;10(1):223-8. Oncol Rep. 2003. PMID: 12469173

5

A human novel gene DERPC on 16q22.1 inhibits prostate tumor cell growth and its expression is decreased in prostate and renal tumors.

Sun M, Ma L, Xu L, Li J, Zhang W, Petrovics G, Makarem M, Sesterhenn I, Zhang M, Blanchette-Mackie EJ, Moul J, Srivastava S, Zou Z. Sun M, et al. Among authors: srivastava s. Mol Med. 2002 Oct;8(10):655-63. Mol Med. 2002. PMID: 12477976 Free PMC article.

6

Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells.

Segawa T, Nau ME, Xu LL, Chilukuri RN, Makarem M, Zhang W, Petrovics G, Sesterhenn IA, McLeod DG, Moul JW, Vahey M, Srivastava S. Segawa T, et al. Among authors: srivastava s. Oncogene. 2002 Dec 12;21(57):8749-58. doi: 10.1038/sj.onc.1205992. Oncogene. 2002. PMID: 12483528

7

p63 expression profile in normal and malignant prostate epithelial cells.

Davis LD, Zhang W, Merseburger A, Young D, Xu L, Rhim JS, Moul JW, Srivastava S, Sesterhenn IA. Davis LD, et al. Among authors: srivastava s. Anticancer Res. 2002 Nov-Dec;22(6C):3819-25. Anticancer Res. 2002. PMID: 12553000

8

A novel neoplastic primary tumor-derived human prostate epithelial cell line.

Ko D, Gu Y, Yasunaga Y, Nakamura K, Srivastava S, Moul JW, Sesterhenn IA, McLeod DG, Arnstein P, Taylor DO, Hukku B, Rhim JS. Ko D, et al. Among authors: srivastava s. Int J Oncol. 2003 Jun;22(6):1311-7. Int J Oncol. 2003. PMID: 12738999

9

Diagnostic potential of prostate-specific antigen expressing epithelial cells in blood of prostate cancer patients.

Gao CL, Rawal SK, Sun L, Ali A, Connelly RR, Bañez LL, Sesterhenn IA, McLeod DG, Moul JW, Srivastava S. Gao CL, et al. Among authors: srivastava s. Clin Cancer Res. 2003 Jul;9(7):2545-50. Clin Cancer Res. 2003. PMID: 12855629

10

PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progression.

Xu LL, Shi Y, Petrovics G, Sun C, Makarem M, Zhang W, Sesterhenn IA, McLeod DG, Sun L, Moul JW, Srivastava S. Xu LL, et al. Among authors: srivastava s. Cancer Res. 2003 Aug 1;63(15):4299-304. Cancer Res. 2003. PMID: 12907594

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,127 results

Search Page